Tivic Health targets FDA approval for Entolimod within 18 months, highlights transformation into biopharma (NASDAQ:TIVC)

Tivic Health targets FDA approval for Entolimod within 18 months, highlights transformation into biopharma

Source link
#Tivic #Health #targets #FDA #approval #Entolimod #months #highlights #transformation #biopharma #NASDAQTIVC